Table 2.
Median CMR at 24–27 weeks* (# of samples) | Rate of Transfer** (Increase in CMR/week) | CMR at 40 weeks* (# of samples) | |
---|---|---|---|
Antigens | |||
AMA-1 | 0.63 (0.5,0.84) (17) | 0.022 ± 0.005 | 0.96 (0.91,1.0) (87) |
EBA-175 | 0.76 (0.76,0.90) (19) | 0.015 ± 0.004 | 0.93 (0.55,1.1) (71) |
MSP-1 | 0.48 (0.42,0.77) (19) | 0.031 ± 0.003 | 0.95 (0.7,1.0) (83) |
TTx | 0.47 (0.33,0.80) (18) | 0.033 ± 0.005 | 0.94 (0.74,1.1) (82) |
MSP-2 | 0.22 (0.18,0.47) (15) | 0.036 ± 0.006 | 0.76 (0.55,0.95) (73) |
DBL5-VAR2 | 0.55 (0.45,0.80) (9) | 0.022 ± 0.004 | 0.93 (0.67,1.1) (55) |
MSP-3 | 0.15 (0.07,0.35) (10) | 0.025 ± 0.003 | 0.51 (0.31,0.66) (49) |
LSA-1 | 0.21 (0.16,0.48) (11) | 0.031 ± 0.007 | 0.66 (0.43,0.89) (52) |
CSP | (0) | 0.013 ± 0.011 | 0.62 (0.23,0.99) (29) |
RESA | 0.26 (0.12,0.28) (3) | 0.019 ± 0.008 | 0.48 (0.35,0.67) (24) |
*Median (IQR) for 24–27 weeks (i.e., end of the second trimester) and CMR at ≥ 40 weeks (i.e., term) are provided. Numbers in (#) indicate sample size.
**The increase in CMR per week of gestation ± standard error, between 24 and 40+ weeks, is shown. The numbers in parentheses (#) indicate sample size.